nicardipine has been researched along with Hypercholesterolemia in 3 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Excerpt | Relevance | Reference |
|---|---|---|
| " An iv Fat Tolerance Test (FTT) was also performed in 8 patients following placebo, treatment with acute nicardipine 20 mg and chronic administration of nicardipine SR." | 1.28 | Evaluation of lipid metabolism during antihypertensive treatment with nicardipine sr. ( Ferrara, LA; Mancini, M; Marotta, T; Pasanisi, F; Russo, O, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohata, I | 1 |
| Sakamoto, N | 1 |
| Nagano, K | 1 |
| Maeno, H | 1 |
| Kaufmann, PA | 1 |
| Frielingsdorf, J | 1 |
| Mandinov, L | 1 |
| Seiler, C | 1 |
| Hug, R | 1 |
| Hess, OM | 1 |
| Pasanisi, F | 1 |
| Marotta, T | 1 |
| Ferrara, LA | 1 |
| Russo, O | 1 |
| Mancini, M | 1 |
3 other studies available for nicardipine and Hypercholesterolemia
| Article | Year |
|---|---|
Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
Topics: Acetates; Animals; Cholesterol; Clofibrate; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins | 1984 |
Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia.
Topics: Calcium Channel Blockers; Case-Control Studies; Coronary Angiography; Coronary Vessels; Diltiazem; E | 1998 |
Evaluation of lipid metabolism during antihypertensive treatment with nicardipine sr.
Topics: Adult; Aged; Blood Pressure; Cholesterol; Delayed-Action Preparations; Fatty Acids, Nonesterified; F | 1992 |